← All trials
NCT01842503
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2014
- Primary completion
- Feb 1, 2017
- Completion date
- Apr 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 25
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Laboratorio Farmaceutico Ct S.r.l.Lead sponsor
- Voisin Consulting, Inc.Collaborator
- Latis SrlCollaborator
- Boston UniversityOverall official - principal investigator
- QuotientCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.